$VCEL

Flynn Sean C. sold $685K of VCEL

Flynn Sean C. (Chief Legal Officer) sold 15,000 shares of Vericel Corp (VCEL) at $45.64 ($0.68M total) on 2026-06-26 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Flynn Sean C.
Published Jun 30, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 30, 2026, 8:08 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VCEL
Neutral
high confidence
Mentioned
$VCEL
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VCELNeutralLow
01

Why it matters

The newest fact is the CFO’s open-market sale of 15,000 shares at a specified price, with holdings after the trade and confirmation of a pre-arranged 10b5-1 plan.

02

Market read

Traders may briefly reassess sentiment toward VCEL due to insider selling, but the 10b5-1 framing limits fundamental read-through.

03

What to watch

The filing does not disclose any change in business outlook, trial/regulatory status, or new contracts—so the only tradable element is short-term sentiment around insider activity.

Relevance 4/10Novelty 5/10Timing: immediately after the Form 4 filing (filed 2026-06-30)

Background

The article is a SEC Form 4 insider transaction disclosure for Vericel Corp (VCEL).

Company-level read

Ticker impact

$VCELNeutralHigh confidence
Context

Vericel CFO Sean Flynn sold 15,000 shares in an open-market transaction at $45.64/share under a pre-arranged 10b5-1 plan.

Expected impact

Low near-term impact; any reaction would be sentiment-driven and likely fade.

Evidence & confidence

The filing is a Form 4 insider sale with a stated 10b5-1 plan, which typically reduces interpretive weight; no new operating, regulatory, or financial datapoints are provided.

Market effects

Minimal; this is company-specific insider activity with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect liquidity needs rather than bearish expectations, so traders may ignore it.

Key entities

  • Vericel Corp

    Subject of the Form 4 insider transaction; CFO Sean Flynn sold shares under a 10b5-1 plan.

  • Sean C. Flynn

    Chief Legal Officer who executed the sale (15,000 shares at $45.64).

Related articles

$VCELMedAI 8/10

Vericel Q2 Earnings Call Highlights

Vericel (NASDAQ: VCEL) reported Q2 earnings call updates. Burn Care revenue rose 22% to about $12M, with Epicel at $10.4M and NexoBrid above $1.5M. 2026 guidance was raised to $330M-$340M total revenue, MACI to $284M-$290M, Burn Care to $46M-$50M, and Q3 revenue to $76.5M-$78.5M. Board authorized a $200M buyback.

$VCELHigh

Vericel Corp (VCEL): Results of Operations and Financial Condition

Vericel Corp (VCEL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991earningsreleaseq22026.htm EX-99.1 Document Exhibit 99.1 Vericel Corporation 25 Blue Sky Drive Burlington, MA 01803 T 617 588-5555 F 617 588-5554 www.vcel.com Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Sh